Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV000513315 | SCV000608765 | pathogenic | not provided | 2023-02-01 | criteria provided, single submitter | clinical testing | CNGB1: PM3:Very Strong, PM2, PP3 |
Molecular Genetics Laboratory, |
RCV001199469 | SCV001162478 | pathogenic | Retinitis pigmentosa | 2020-01-09 | criteria provided, single submitter | research | |
Invitae | RCV000513315 | SCV002207755 | pathogenic | not provided | 2024-01-29 | criteria provided, single submitter | clinical testing | This sequence change falls in intron 28 of the CNGB1 gene. It does not directly change the encoded amino acid sequence of the CNGB1 protein. This variant is present in population databases (rs749199721, gnomAD 0.008%). This variant has been observed in individuals with inherited retinal dystrophy (PMID: 32037395, 33847019; Invitae). ClinVar contains an entry for this variant (Variation ID: 369953). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. |
Bioscientia Institut fuer Medizinische Diagnostik Gmb |
RCV000408898 | SCV000484923 | likely pathogenic | Retinitis pigmentosa 45 | no assertion criteria provided | clinical testing |